Vaughan David Investments’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.55M Buy
34,992
+116
+0.3% +$17.3K 0.11% 106
2026
Q1
$5.11M Sell
34,876
-100
-0.3% -$15.4K 0.11% 103
2025
Q4
$5.41M Buy
34,976
+4,710
+16% +$705K 0.12% 103
2025
Q3
$4.21M Buy
30,266
+1,470
+5% +$199K 0.09% 105
2025
Q2
$3.88M Buy
28,796
+1,643
+6% +$222K 0.09% 106
2025
Q1
$3.96M Sell
27,153
-299
-1% -$43.4K 0.09% 103
2024
Q4
$3.78M Buy
27,452
+5,437
+25% +$796K 0.09% 104
2024
Q3
$3.39M Buy
22,015
+1,056
+5% +$160K 0.08% 107
2024
Q2
$3.06M Buy
20,959
+6,012
+40% +$862K 0.08% 108
2024
Q1
$2.21M Sell
14,947
-3,185
-18% -$457K 0.05% 117
2023
Q4
$2.47M Sell
18,132
-14,007
-44% -$1.82M 0.07% 110
2023
Q3
$4.14M Sell
32,139
-216
-0.7% -$28.7K 0.13% 100
2023
Q2
$4.29M Sell
32,355
-407
-1% -$53.7K 0.13% 105
2023
Q1
$4.24M Buy
32,762
+218
+0.7% +$28.5K 0.13% 103
2022
Q4
$4.42M Buy
32,544
+794
+3% +$105K 0.13% 102
2022
Q3
$3.85M Sell
31,750
-299
-0.9% -$38.5K 0.13% 104
2022
Q2
$4.11M Sell
32,049
-638
-2% -$83.6K 0.13% 100
2022
Q1
$4.48M Buy
32,687
+214
+0.7% +$28.3K 0.13% 100
2021
Q4
$4.58M Buy
32,473
+566
+2% +$75.2K 0.13% 100
2021
Q3
$4.06M Sell
31,907
-2,425
-7% -$321K 0.13% 97
2021
Q2
$4.32M Sell
34,332
-1,245
-3% -$153K 0.14% 97
2021
Q1
$4.15M Buy
35,577
+3,879
+12% +$448K 0.13% 94
2020
Q4
$3.6M Buy
31,698
+5,190
+20% +$567K 0.12% 92
2020
Q3
$2.8M Buy
26,508
+2,824
+12% +$297K 0.11% 93
2020
Q2
$2.37M Sell
23,684
-828
-3% -$81.7K 0.1% 94
2020
Q1
$2.17M Sell
24,512
-483
-2% -$46.9K 0.1% 96
2019
Q4
$2.55M Buy
24,995
+1,263
+5% +$121K 0.09% 95
2019
Q3
$2.14M Buy
23,732
+1,682
+8% +$154K 0.08% 96
2019
Q2
$2.04M Buy
22,050
+1,586
+8% +$143K 0.08% 96
2019
Q1
$1.88M Buy
20,464
+4,344
+27% +$392K 0.08% 98
2018
Q4
$1.4M Buy
+16,120
New +$1.46M 0.07% 103

Other funds holding XLV

Vaughan David Investments's XLV Position: Q2 2026 in Review

Vaughan David Investments increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.33% in Q2 2026, buying an estimated $17.3K and bringing the position to 34,992 shares worth $5.55M. The position accounts for 0.11% of the portfolio, ranked #106.

Vaughan David Investments first reported a position in XLV in Q4 2018 and has held it in 31 quarters since. 1,853 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Vaughan David Investments held 34,992 shares of State Street Health Care Select Sector SPDR ETF worth $5.55M as of Q2 2026.
  • Vaughan David Investments bought 116 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $17.3K.
  • State Street Health Care Select Sector SPDR ETF made up 0.11% of Vaughan David Investments's portfolio in Q2 2026, its #106 holding.
  • Vaughan David Investments first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2018 and has held it in 31 quarters since.
  • 1,853 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Vaughan David Investments's 13F filing for Q2 2026, filed 11 Aug 2026.